TelyRx Holdings Inc. (TSX:TELY)
2.600
0.00 (0.00%)
At close: Aug 14, 2026
TelyRx Holdings Revenue
TelyRx Holdings had revenue of $22.67M USD in the quarter ending June 30, 2026, with 142.67% growth. This brings the company's revenue in the last twelve months to $68.72M. In the year 2025, TelyRx Holdings had annual revenue of $42.92M with 350.27% growth.
Revenue (ttm)
$68.72M
Revenue Growth
+350.27%
P/S Ratio
1.30
Revenue / Employee
n/a
Employees
n/a
Market Cap
127.01M CAD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 42.92M | 33.39M | 350.27% |
| Dec 31, 2024 | 9.53M | 9.51M | 35,207.41% |
| Dec 31, 2023 | 27.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
TelyRx Holdings News
- 5 days ago - TelyRx Holdings Earnings Call Transcript: Q2 2026 - Transcripts
- 5 days ago - TelyRx Holdings Earnings release: Q2 2026 - Filings
- 5 days ago - TelyRx Holdings Registration statement: Q2 2026 - Filings
- 5 days ago - TelyRx Holdings Registration statement: Q2 2026 - Filings
- 5 days ago - TelyRx Holdings Slides: Q2 2026 - Filings
- 5 days ago - TelyRx Holdings Slides - Filings
- 11 days ago - TelyRx Launches New Brand and Digital Experience Inspired by Patient Feedback - PRNewsWire
- 22 days ago - TelyRx to Host Second Quarter 2026 Financial Results Conference Call on Monday, August 10, 2026 at 8:30 am ET - Newsfile Corp